Back to search
FDAFDA · Food and drugs·Recall number D-0607-2018

Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01

Published March 28, 2018 · Recall initiated: March 5, 2018

Summary

FDA records drug Class III recall D-0607-2018, published March 28, 2018 and initiated March 5, 2018. Recalling firm: Pine Pharmaceuticals, LLC; Status: Terminated; Reported quantity: 136 units; Lot: Lot#: 18098@1, Exp. 7/16/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pine Pharmaceuticals, LLC
Distributor
NY only
Lot
Lot#: 18098@1, Exp. 7/16/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01 recalled?

Yes. FDA published recall D-0607-2018 on March 28, 2018. Reported hazard: Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter